PubMed=7510115; DOI=10.1038/bjc.1994.78; PMCID=PMC1968867
Volker Jochen Mobus, Roland Moll, Claus-Dieter Gerharz, Dirk Gunter Kieback, Wolfgang Weikel, G. Hoffmann, Rolf Kreienberg;
Establishment of new ovarian and colon carcinoma cell lines: differentiation is only possible by cytokeratin analysis.
Br. J. Cancer 69:422-428(1994)

PubMed=21559638; DOI=10.3892/ijo.5.4.753
Christine Will, Olaf G. Wilhelm, Sandra Hohl, Volker Jochen Mobus, Ulrich H. Weidle, Rolf Kreienberg, Fritz Janicke, Manfred Schmitt, Henner Graeff;
Expression of urokinase-type plasminogen-activator (uPA) and its receptor (uPAR) in human ovarian-cancer cells and in-vitro invasion capacity.
Int. J. Oncol. 5:753-761(1994)

PubMed=11242531; DOI=10.1089/10430340150504019
Ansgar Bruning, Tanja Kohler, Sven Roy Quist, Shan Wang-Gohrke, Volker Jochen Mobus, Rolf Kreienberg, Ingo Bernard Runnebaum;
Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphaVbeta3.
Hum. Gene Ther. 12:391-399(2001)

PubMed=11925137; DOI=10.1006/gyno.2002.6597
Matthias Oppitz, Volker Jochen Mobus, S. Brock, Ulrich Drews;
Muscarinic receptors in cell lines from ovarian carcinoma: negative correlation with survival of patients.
Gynecol. Oncol. 85:159-164(2002)

DOI=10.5282/edoc.3898
Nicole Isabel Euer;
Identification of target genes for the therapy and diagnosis of ovarian carcinoma.
Thesis PhD (2005); Ludwig Maximilians University of Munich; Munich; Germany

PubMed=15706405; DOI=10.3892/or.13.3.375
Nicole Isabel Euer, Sepp Kaul, Helmut Deissler, Volker Jochen Mobus, Robert Zeillinger, Ulrich H. Weidle;
Identification of L1CAM, Jagged2 and neuromedin U as ovarian cancer-associated antigens.
Oncol. Rep. 13:375-387(2005)